PULMOPHARMA ApS is a Danish APS based in Ebeltoft, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2014, the company reported revenue of -49,4 t kr. in its latest annual filing.
Solidity ratio Equity ÷ Total assets × 100 2021 2025
Liquidity ratio Current assets ÷ Short-term debt 2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2025
EBITDA — year on year DKK millions 0M 0M 0M -1M -1M 2021: 0M 0M 2021 2022: 0M 0M 2022 2023: 0M 0M 2023 2024: 0M 0M 2024 2025: 0M 0M 2025
Key figures Annual report 2025 Revenue -0 mio. kr. +141% EBITDA -0 mio. kr. -141% Net profit -0 mio. kr. -141% Total assets 13,6 mio. kr. +46% Equity 11,4 mio. kr. +55% Employees — —
Legal name
PULMOPHARMA ApS
Founded
1 November 2014 · 11 years
Financial year
January – December
Signatory rights
Virksomheden tegnes af bestyrelsens formand i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er udvikling af et nyt medicinsk præparat.
(no translation available)
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in Syddjurs All Denmark companiesFinancial development In its most recent annual report (2025), PULMOPHARMA ApS reported a gross profit of -49,4 t kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 49,4 t kr..
At the end of 2025, equity financed 84.2% of the balance sheet, and current assets covered short-term debt 1.8 times. PULMOPHARMA ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of PULMOPHARMA ApS? PULMOPHARMA ApS is registered with CVR / Virk under CVR 36428023.
What is the revenue of PULMOPHARMA ApS? PULMOPHARMA ApS reported revenue of -49,4 t kr. in 2025.
Who is the chairman of PULMOPHARMA ApS? Torben Ballegaard Sørensen chairs the board of PULMOPHARMA ApS, in role since 2021.
Where is PULMOPHARMA ApS headquartered? PULMOPHARMA ApS's registered address is Bøgebjerg 2, 2. 4.